Quality of Life after Salivary Gland Surgery
- PMID: 27092786
- DOI: 10.1159/000442140
Quality of Life after Salivary Gland Surgery
Abstract
Quality of life (QoL) has been recognized as an important endpoint in addition to disease-related and global survival. It is particularly important for patients with salivary gland neoplastic disease. For patients who are undergoing benign salivary gland tumor surgery, cosmetic and functional outcomes are extremely important, as these patients' psychological well-being and ability to function in society can be severely impacted. The following issues related to surgical treatment are discussed: incision, loss of local tissue sensation, development of Frey's syndrome, facial nerve function, and cosmesis. Improvements in the placement of the incision combined with additional minimally invasive procedures have improved QoL. The ultimate goal of benign parotid neoplastic surgery is complete tumor excision while avoiding cosmetic and functional damage, which includes preservation of the function of the facial nerve and its branches; this is the key to maintaining preoperative levels of QoL. There are many measures available to improve cosmesis that have minimal morbidity and that, when used, can provide significant improvements in patient outcomes. The treatment of malignant salivary gland neoplasms is primarily directed at treating the malignancy. When surgical treatment affects important neighboring structures, such as the lingual or hypoglossal nerves, as in submandibular/sublingual cancer, there is a tremendous effect on QoL if postoperative dysfunction of these structures results. Often, this treatment involves using ancillary surgical procedures, such as neck dissection, or nonsurgical treatment, such as radiation therapy. The effect of such multi-modality treatment on QoL is significant. The treatment of underlying salivary disease is often overshadowed by these adjunctive treatments.
© 2016 S. Karger AG, Basel.
Similar articles
-
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16. Ann Surg Oncol. 2012. PMID: 23070784
-
Health-related quality of life after treatment for neoplasia of the major salivary glands: a pilot study.Br J Oral Maxillofac Surg. 2016 Sep;54(7):806-11. doi: 10.1016/j.bjoms.2016.05.018. Epub 2016 May 30. Br J Oral Maxillofac Surg. 2016. PMID: 27256797
-
Health-related quality of life in patients with major salivary gland carcinoma.Eur Arch Otorhinolaryngol. 2018 Apr;275(4):997-1003. doi: 10.1007/s00405-018-4914-7. Epub 2018 Feb 24. Eur Arch Otorhinolaryngol. 2018. PMID: 29478078
-
Surgery for Malignant Submandibular Gland Neoplasms.Adv Otorhinolaryngol. 2016;78:104-12. doi: 10.1159/000442130. Epub 2016 Apr 12. Adv Otorhinolaryngol. 2016. PMID: 27092787 Review.
-
Surgery for Malignant Sublingual and Minor Salivary Gland Neoplasms.Adv Otorhinolaryngol. 2016;78:113-9. doi: 10.1159/000442131. Epub 2016 Apr 12. Adv Otorhinolaryngol. 2016. PMID: 27092950 Review.
Cited by
-
[Posttherapeutic quality of life after treatment of salivary gland cancer].HNO. 2023 Apr;71(4):250-255. doi: 10.1007/s00106-023-01286-x. Epub 2023 Feb 24. HNO. 2023. PMID: 36826483 Review. German.
-
Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.Oral Oncol. 2021 Apr;115:105166. doi: 10.1016/j.oraloncology.2020.105166. Epub 2021 Feb 11. Oral Oncol. 2021. PMID: 33581505 Free PMC article.
-
Outpatient Submaxillectomy Using Active Drains. Safety of the Procedure and Patient Satisfaction.J Maxillofac Oral Surg. 2021 Nov 26:1-5. doi: 10.1007/s12663-021-01672-4. Online ahead of print. J Maxillofac Oral Surg. 2021. PMID: 34866839 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical